122 completed. 122 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 122 | Completed 122 |
| Phase 2 | 3 | Completed 3 |
Follow Tetanus: new trials by email Literature Review of Tetanus trials Research Report on Tetanus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp)), 23-valent Pneumococcal Polysaccharide Vaccine (PPV23), Tdcp - Diphtheria, Tetanus | Phase 2 / Phase 3 | Completed | CanSino Biologics Inc. | 1820 | 2024-12-20 | 2026-08-26 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over TTVA, TT - Tetanus | Phase 3 | Completed | CanSino Biologics Inc. | 1000 | 2024-03-20 | 2026-08-05 |
| Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine Tetanus Toxoid (Adsorbed) - Tetanus, Tetanus Vaccine | Phase 3 | Completed | Beijing Minhai Biotechnology Co., Ltd | 1240 | 2024-02-29 | 2026-08-03 |
| Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population Investigational tetanus vaccine, adsorbed, Control tetanus vaccine, adsorbed - Tetanus | Phase 3 | Completed | Sinovac Life Sciences Co., Ltd. | 1260 | 2023-09-01 | 2024-07-12 |
| Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus TNM002, Human tetanus immunoglobulin (HTIG) - Tetanus | Phase 3 | Completed | Zhuhai Trinomab Pharmaceutical Co., Ltd. | 675 | 2022-12-22 | 2026-09-01 |
| A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age RSV MAT vaccine, dTpa vaccine - Respiratory Syncytial Virus Infections | Phase 3 | Completed | GlaxoSmithKline | 9 | 2022-02-02 | 2023-04-07 |
| Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed), Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed) - Streptococcus Pneumoniae Infections | Phase 3 | Completed | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 1110 | 2021-09-16 | 2025-02-10 |
| Tdap Vaccine Safety for Plasma Donors Adacel - Tetanus | Phase 2 / Phase 3 | Completed | GCAM Inc. | 110 | 2020-02-03 | 2022-12-06 |
| Confirmatory Study of BK1310 in Healthy Infants DPT-IPV-Hib, Hib vaccine, DPT-IPV - Tetanus, Diphtheria | Phase 3 | Completed | Tanabe Pharma Corporation | 267 | 2019-04-01 | 2026-01-06 |
| Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains) - Diphtheria, Tetanus | Phase 2 / Phase 3 | Completed | LG Chem | 60 | 2018-07-18 | 2026-09-03 |
| Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects Boostrix - Diphtheria-Tetanus-acellular Pertussis Vaccines | Phase 3 | Completed | GlaxoSmithKline | 448 | 2018-01-26 | 2020-10-27 |
| To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children BR-TD-1001, Td-pur inj - Diphtheria, Tetanus | Phase 3 | Completed | Boryung Biopharma Co., Ltd. | 218 | 2016-10-20 | 2020-11-20 |
| A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia Infanrix-IPV/Hib - Diphtheria, Tetanus | Phase 3 | Completed | GlaxoSmithKline | 235 | 2016-09-13 | 2019-09-24 |
| DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 53 | 2016-07-14 | 2022-04-05 |
| Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth Hexaxim® - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 354 | 2015-04-20 | 2022-04-05 |
| Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS DTaP-IPV combination vaccine, DTaP vaccine and IPV vaccine - Diphtheria, Tetanus | Phase 3 | Completed | Boryung Pharmaceutical Co., Ltd | 476 | 2015-02-02 | 2023-06-28 |
| DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants DTaP-IPV/Hib Combined vaccine, DTaP-IPV vaccine and Hib vaccine - Tetanus, Diphtheria | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 424 | 2014-10-01 | 2022-04-25 |
| Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants Infanrix hexa, Pediarix, ActHIB - Poliomyelitis, Diphtheria | Phase 3 | Completed | GlaxoSmithKline | 585 | 2014-04-16 | 2019-11-27 |
| Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301), Adsorbed Diphtheria-Tetanus Combined Toxoid (DT toxoid) - Diphtheria, Tetanus | Phase 3 | Completed | Tanabe Pharma Corporation | 446 | 2014-04-01 | 2026-01-06 |
| DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants DTaP-IPV-Hep B-PRP~T combined vaccine, DTaP-IPV//PRP~T and Hepatitis B vaccine - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 310 | 2014-03-01 | 2017-04-26 |
Showing 20 of 122. Sign in to see all of them.
Diphtheria (110) · Whooping Cough (73) · Haemophilus Infections (57) · Poliomyelitis (56) · Hepatitis B (52) · Virus Diseases (6) · Meningococcal Infections (5) · Bacterial Infections (4) · Influenza, Human (4) · Meningitis (3) · Pneumococcal Infections (3) · Measles (2) · Meningitis, Bacterial (2) · Meningitis, Meningococcal (2)
Bacterial Infections and Mycoses (122) · Clostridium Infections (122) · Gram-Positive Bacterial Infections (122) · Infections (122) · Bacterial Infections (118) · Actinomycetales Infections (110) · Corynebacterium Infections (110) · Gram-Negative Bacterial Infections (93) · Virus Diseases (76) · Respiratory Tract Diseases (74) · Respiratory Tract Infections (74) · Bordetella Infections (73) · Nervous System Diseases (60) · Neuroinflammatory Diseases (60) · RNA Virus Infections (60)
Tetanus Toxoid (21) · Diphtheria-Tetanus-acellular Pertussis Vaccines (16) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (16) · Boostrix (13) · Hiberix (11) · adacel (8) · DTaP-IPV-HB-PRP-T vaccine (6) · Heptavalent Pneumococcal Conjugate Vaccine (6) · Pentavac (6) · pentacel (6) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (5) · 13-valent pneumococcal vaccine (4) · HibTITER protein, Haemophilus influenzae (4) · Poliovirus Vaccine, Oral (4) · RIX4414 vaccine (4)
GlaxoSmithKline (56) · Sanofi Pasteur, a Sanofi Company (31) · Sanofi (10) · Merck Sharp & Dohme LLC (6) · CanSino Biologics Inc. (2) · Crucell Holland BV (2) · MCM Vaccines B.V. (2) · Novartis Vaccines (2) · Tanabe Pharma Corporation (2) · Beijing Minhai Biotechnology Co., Ltd (1) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (1) · Boryung Biopharma Co., Ltd. (1) · Boryung Pharmaceutical Co., Ltd (1) · GCAM Inc. (1) · Heinrich-Heine University, Duesseldorf (1)
United States (18) · China (17) · Philippines (10) · Germany (9) · South Korea (9) · Thailand (7) · India (6) · France (5) · Vietnam (5) · Costa Rica (4) · Japan (4) · Russia (4) · South Africa (4) · Colombia (3) · Mexico (3)
Anne Fiquet, MD (1) · Chuanlin Wang, MD (1) · Dagmar Dilloo, MD, PhD (1) · Edison Alberto, MD (1) · HJ Jung (1) · Hanqing He (1) · Jong Hyun Kim (1) · Josefina Carlos, MD (1) · Lin Du, Doctor (1)
PMID 17716936, PMID 14670310, PMID 15882526, PMID 17090650, PMID 19095033, PMID 19117896, PMID 19952980, PMID 20189491, PMID 20439595, PMID 20950456, PMID 21219984, PMID 21441781, PMID 21807056, PMID 21817954, PMID 21945698, PMID 22001281, PMID 22157567, PMID 22273029, PMID 22349525, PMID 22475857, PMID 22531237, PMID 22691430, PMID 23032160, PMID 23783081, PMID 23966556, PMID 25765966, PMID 25882172, PMID 27288217, PMID 27510380, PMID 27846055, PMID 27846058, PMID 27879555, PMID 29576304, PMID 29789243, PMID 29960800, PMID 31307216, PMID 32048889, PMID 32307307, PMID 34931494, PMID 38582691, PMID 40628965, PMID 41276263, PMID 42688305
2015 (1), 2018 (1)